3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Dermatologic
1
Conditions
Keratosis, Actinic
23
Skin Neoplasms
7
Melanoma
7
Colorectal Neoplasms
5
Carcinoma, Non-Small-Cell Lung
5
Pancreatic Neoplasms
4
Neoplasm Metastasis
4
Carcinoma, Squamous Cell
4
Carcinoma, Renal Cell
3
Stomach Neoplasms
2
Ovarian Neoplasms
2
Neoplasms, Basal Cell
2
Neoplasms
2
Lung Neoplasms
2
Fallopian Tube Neoplasms
2
Colonic Neoplasms
2
Carcinoma, Merkel Cell
2
Carcinoma, Basal Cell
2
Urinary Bladder Neoplasms
1
Triple Negative Breast Neoplasms
1
Thyroid Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Small Cell Lung Carcinoma
1
Skin Diseases
1
Sezary Syndrome
1
Sarcoma
1
Prostatic Neoplasms
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Neoplasms, Squamous Cell
1
Interventions
sonidegib
4
HhAntag691
4
gusacitinib
3
IPI-926
3
tazarotene
2
Photochemotherapy
2
Drug Evaluation
2
Aminolevulinic Acid
2
1-phenyl-3,3-dimethyltriazene
2
merphos
1
Watchful Waiting
1
Vincristine
1
Solutions
1
Sirolimus
1
Red Light
1
Nivolumab
1
NVP-BKM120
1
Microarray Analysis
1
Methotrexate
1
Mental Status and Dementia Tests
1
Mass Spectrometry
1
Ipilimumab
1
Gene Expression Profiling
1
Fluorouracil
1
Etoposide
1
Cyclophosphamide
1
Comparative Genomic Hybridization
1
Carnitine
1
Carboplatin
1
Blue Light
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Basal Cell Nevus Syndrome
×
Fluorouracil
×
Dermatologic
×
Clear all
NCT02550678
2018-06-06
ASN-002-001
Ascend Biopharmaceuticals Ltd
Phase 1/2
Completed
16 enrolled